Delivery Order SPE2DB20D7059-SPE2DB24FPXQ9
Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $2,264.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $18,047.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The award covers the supply of 4564755730 - VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product, with an ultimate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,665.89 firm fixed-price delivery order is for the supply of VYVANSE 70 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
- This federal contract award, valued at $2,041.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
- This federal contract award, valued at $3,356.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of March 20, 2025 and a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,276.40, is for the supply of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 5, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $4,615.08, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of VYVANSE 10 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying...
- This federal contract award, valued at $5,829.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a prescription medication, with a completion date of May 10, 2024. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $2,704.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a prescription medication, with an ultimate completion date of October 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,378.53 for the procurement of VYVANSE 20 MG CAPSULE 100S. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 21, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...